The role of cytomegalovirus in the physiological and clinical effects of concussion
Active Project Grant Awarded Last action
- Award ID
- R01NS135776
- Recipient
-
The Medical College Of Wisconsin, Inc. UEI E8VWJXMMUQ67
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,176,705
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date 72% complete
- Place of performance
- Wauwatosa, WI 53226, USA
Award details come from USAspending.gov.
Description
- Abstract
- Sport-related concussion (SRC) is a major public health concern, causing chronic symptoms in significant numbers of people, and increasing the risk for adverse long-term health outcomes. Prognostic models for predicting recovery following SRC are limited, and identifying potential modifiable factors is critical for understanding mechanism and ultimately personalizing treatment. One such potential factor is cytomegalovirus (CMV), a common neurotropic herpesvirus, that is reactivated by inflammation and has been implicated as a pathological CO-factor in multiple inflammatory diseases. Given that SRC results in an acute inflammatory response, this application proposes to investigate the role of CMV in the physiological and clinical outcomes following SRC. To ensure a well-powered and rigorous assessment of our hypotheses, we propose leveraging an existing cohort of athletes enrolled in the concussion assessment, research and education (care) consortium. Participants (191 athletes with SRC, 151 contact controls, and 155 non-contact controls) previously completed MRI scans, clinical assessments, and blood draws at baseline (pre-injury), 24 hours post-injury, when asymptomatic, and 7 days following unrestricted return to play. Through these baseline and follow-up assessments of brain structure and function, blood-based biomarkers, and clinical phenotypes this study aims to test the hypothesis that CMV serostatus moderates SRC outcomes. The major outcomes include microstructural changes on diffusion MRI, cortical thickness, and resting state functional connectivity (aim 1), circulating measures of neural injury and inflammation (aim 2), and severity and duration of post-injury symptoms and cognitive performance (aim 3). Additionally, the study will use multivariate biclustering to identify subgroups of participants with distinct physiological and clinical trajectories (exploratory aim 4). Within each aim, the study will also explore the role of two additional common, neurotropic herpesviruses, i.e., herpes simplex virus 1 (HSV-1) and epstein barr virus (EBV), which have recently been implicated in alzheimer's disease and multiple sclerosis, respectively. The information gathered from this research will advance our understanding of the complex biopsychosocial forces shaping response to and recovery from SRC, potentially improving the precision medicine approach to the assessment and management of patients with SRC and opening a new avenue of treatment given the existence of well-tolerated anti-CMV medications.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $37,120 | |
| Amendment | $334,093 | |
| Amendment | $334,093 | |
| Amendment | $407,525 | |
| Amendment | $531,937 | |
| Original award | $531,937 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Trustees Of Indiana University | $30,804 | |
| University Of Oklahoma | $84,048 | |
| Laureate Institute For Brain Research, Inc. | $99,462 | |
| University Of Oklahoma | $106,156 | |
| Trustees Of Indiana University | $63,425 | |
| Laureate Institute For Brain Research, Inc. | $96,943 | |
| University Of Oklahoma | $109,597 | |
| Trustees Of Indiana University | $77,427 | |
| Laureate Institute For Brain Research, Inc. | $81,862 |
Quick answers
Who received award R01NS135776?
R01NS135776 was awarded to The Medical College Of Wisconsin, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on January 17, 2024.
How much is award R01NS135776 worth?
$2,176,705 has been obligated on R01NS135776.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award